JASMINE DILLARD: Open Payments
NPI 1841847753 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,053 in 106 payments from 25 companies in 2025. Trend: 2023 $917 · 2024 $1,950 · 2025 $2,053
Food & beverage: $2,053
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $259 |
| ABBVIE INC. | 22 | $249 |
| UCB, Inc. | 11 | $216 |
| Collegium Pharmaceutical, Inc. | 10 | $163 |
| Medtronic, Inc. | 1 | $161 |
| Lundbeck LLC | 6 | $155 |
| Amgen Inc. | 4 | $85 |
| Neurelis, Inc. | 4 | $79 |
| CSL Behring | 3 | $79 |
| Boston Scientific Corporation | 3 | $63 |
Products named: NURTEC ODT, INTELLIS ADAPTIVESTIM, VYEPTI, Zilbrysq, QULIPTA, XTAMPZA, UPLIZNA, VALTOCO.
Industry payments across FL — which companies pay providers there.
